161 related articles for article (PubMed ID: 24255633)
21. A year of anaplastic large cell kinase testing for lung carcinoma: pathological and technical perspectives.
Desai SS; Shah AS; Prabhash K; Jambhekar NA
Indian J Cancer; 2013; 50(2):80-6. PubMed ID: 23979196
[TBL] [Abstract][Full Text] [Related]
22. Validation and utilization of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinoma and alveolar soft part sarcoma.
Pradhan D; Roy S; Quiroga-Garza G; Cieply K; Mahaffey AL; Bastacky S; Dhir R; Parwani AV
Diagn Pathol; 2015 Sep; 10():179. PubMed ID: 26415891
[TBL] [Abstract][Full Text] [Related]
23. [Clinicopathological features and prognosis of renal cell carcinoma with sarcomatoid differentiation].
Jiang Y; Su G; Yu W; Li J; Lu Q; Li Y; Zhang W
Zhonghua Zhong Liu Za Zhi; 2015 Nov; 37(11):823-6. PubMed ID: 26887511
[TBL] [Abstract][Full Text] [Related]
24. [Clinicopatholigic features of renal cell carcinoma associated with chromosome X inversion harboring gene fusions involving TFE3].
Zhao YN; Wang XT; Xia QY; Wang GP; Sun SY; Zhao LF; Zhou XJ; Rao Q
Zhonghua Bing Li Xue Za Zhi; 2018 Aug; 47(8):574-579. PubMed ID: 30107660
[No Abstract] [Full Text] [Related]
25. Anaplastic lymphoma kinase status in lung cancers: An immunohistochemistry and fluorescence
Murthy SS; Rajappa SJ; Gundimeda SD; Mallavarapu KM; Ayyagari S; Yalavarthi P; Fonseca D; Paliwal P; Nair H; Koppula V; Raju K; Rao ST
Indian J Cancer; 2017; 54(1):231-235. PubMed ID: 29199697
[TBL] [Abstract][Full Text] [Related]
26. Equivocal ALK fluorescence in-situ hybridization (FISH) cases may benefit from ancillary ALK FISH probe testing.
Selinger C; Cooper W; Lum T; McNeil C; Morey A; Waring P; Amanuel B; Millward M; Peverall J; Van Vliet C; Christie M; Tran Y; Diakos C; Pavlakis N; Gill AJ; O'Toole S
Histopathology; 2015 Nov; 67(5):654-63. PubMed ID: 25847523
[TBL] [Abstract][Full Text] [Related]
27. [Histologic subtyping of poorly-differentiated solid lung cancer with molecular testing for epidermal growth factor receptor mutation and ALK gene rearrangement: an analyses of 167 cases].
Fang F; Wang YX; Hu ST; Yang L; Di J; Liu DG; Lyu N
Zhonghua Bing Li Xue Za Zhi; 2018 Jun; 47(6):432-437. PubMed ID: 29886587
[No Abstract] [Full Text] [Related]
28. Clear cell-papillary renal cell carcinoma of the kidney not associated with end-stage renal disease: clinicopathologic correlation with expanded immunophenotypic and molecular characterization of a large cohort with emphasis on relationship with renal angiomyoadenomatous tumor.
Aron M; Chang E; Herrera L; Hes O; Hirsch MS; Comperat E; Camparo P; Rao P; Picken M; Michal M; Montironi R; Tamboli P; Monzon F; Amin MB
Am J Surg Pathol; 2015 Jul; 39(7):873-88. PubMed ID: 25970682
[TBL] [Abstract][Full Text] [Related]
29. Biphasic alveolosquamoid renal carcinoma: a histomorphological, immunohistochemical, molecular genetic, and ultrastructural study of a distinctive morphologic variant of renal cell carcinoma.
Petersson F; Bulimbasic S; Hes O; Slavik P; Martínek P; Michal M; Gomolčáková B; Hora M; Damjanov I
Ann Diagn Pathol; 2012 Dec; 16(6):459-69. PubMed ID: 23036259
[TBL] [Abstract][Full Text] [Related]
30. t(6;11) renal cell carcinoma (RCC): expanded immunohistochemical profile emphasizing novel RCC markers and report of 10 new genetically confirmed cases.
Smith NE; Illei PB; Allaf M; Gonzalez N; Morris K; Hicks J; Demarzo A; Reuter VE; Amin MB; Epstein JI; Netto GJ; Argani P
Am J Surg Pathol; 2014 May; 38(5):604-14. PubMed ID: 24618616
[TBL] [Abstract][Full Text] [Related]
31. New methods for ALK status diagnosis in non-small-cell lung cancer: an improved ALK immunohistochemical assay and a new, Brightfield, dual ALK IHC-in situ hybridization assay.
Nitta H; Tsuta K; Yoshida A; Ho SN; Kelly BD; Murata LB; Kosmeder J; White K; Ehser S; Towne P; Schemp C; McElhinny A; Ranger-Moore J; Bieniarz C; Singh S; Tsuda H; Grogan TM
J Thorac Oncol; 2013 Aug; 8(8):1019-31. PubMed ID: 23817194
[TBL] [Abstract][Full Text] [Related]
32. RBM10-TFE3 renal cell carcinoma characterised by paracentric inversion with consistent closely split signals in break-apart fluorescence in-situ hybridisation: study of 10 cases and a literature review.
Kato I; Furuya M; Baba M; Kameda Y; Yasuda M; Nishimoto K; Oyama M; Yamasaki T; Ogawa O; Niino H; Nakaigawa N; Yano Y; Sakamoto K; Urata Y; Mikami K; Yamasaki S; Tanaka R; Takagi T; Kondo T; Nagashima Y
Histopathology; 2019 Aug; 75(2):254-265. PubMed ID: 30908700
[TBL] [Abstract][Full Text] [Related]
33. Identification of anaplastic lymphoma kinase fusion in clear cell renal carcinoma (ALK-tRCC): a precision oncology medicine case report.
Varchetta V; Campanella C; Rossi M; Verzaro R; Vitale M; Soda G; Mancuso A
Recenti Prog Med; 2021 Jan; 112(1):14e-15e. PubMed ID: 33512368
[TBL] [Abstract][Full Text] [Related]
34. Anaplastic lymphoma kinase (ALK) gene rearrangement in non-small cell lung cancer (NSCLC): results of a multi-centre ALK-testing.
V Laffert M; Warth A; Penzel R; Schirmacher P; Jonigk D; Kreipe H; Schildhaus HU; Merkelbach-Bruse S; Büttner R; Reu S; Kerler R; Jung A; Kirchner T; Wölfel C; Petersen I; Rodriguez R; Jochum W; Bartsch H; Fisseler-Eckhoff A; Berg E; Lenze D; Dietel M; Hummel M
Lung Cancer; 2013 Aug; 81(2):200-6. PubMed ID: 23669200
[TBL] [Abstract][Full Text] [Related]
35. Utilization of a TFE3 break-apart FISH assay in a renal tumor consultation service.
Green WM; Yonescu R; Morsberger L; Morris K; Netto GJ; Epstein JI; Illei PB; Allaf M; Ladanyi M; Griffin CA; Argani P
Am J Surg Pathol; 2013 Aug; 37(8):1150-63. PubMed ID: 23715164
[TBL] [Abstract][Full Text] [Related]
36. Adult renal cell carcinoma with rhabdoid differentiation: incidence and clinicopathologic features in Chinese patients.
Yang X; Xi C; Jin J; Zhou L; Su J; Liu L; Liu Y
Ann Diagn Pathol; 2015 Apr; 19(2):57-63. PubMed ID: 25708024
[TBL] [Abstract][Full Text] [Related]
37. Multiplex fluorescence in situ hybridisation to detect anaplastic lymphoma kinase and ROS proto-oncogene 1 receptor tyrosine kinase rearrangements in lung cancer cytological samples.
Zito Marino F; Rossi G; Cozzolino I; Montella M; Micheli M; Bogina G; Munari E; Brunelli M; Franco R
J Clin Pathol; 2020 Feb; 73(2):96-101. PubMed ID: 31562206
[TBL] [Abstract][Full Text] [Related]
38. Validation of ALK/ROS1 Dual Break Apart FISH Probe probe in non-small-cell lung cancer.
Lim SM; Chang H; Cha YJ; Liang S; Tai YC; Li G; Pestova E; Policht F; Perez T; Soo RA; Park WY; Kim HR; Shim HS; Cho BC
Lung Cancer; 2017 Sep; 111():79-83. PubMed ID: 28838404
[TBL] [Abstract][Full Text] [Related]
39. A comparative analysis of immunohistochemistry and fluorescent
Wagle PB; Jambhekar NA; Kumar R; Prabhash K; Pramesh CS; Desai SB; Noronha V; Karimundackal G; Shah A; Joshi A; Laskar SG; Jiwnani S; Pai T; Agarwal JP
Indian J Cancer; 2017; 54(1):148-154. PubMed ID: 29199679
[TBL] [Abstract][Full Text] [Related]
40. A case of anaplastic lymphoma kinase-positive renal cell carcinoma coincident with Hodgkin lymphoma.
Oyama Y; Nishida H; Kusaba T; Kadowaki H; Arakane M; Daa T; Watanabe D; Akita Y; Sato F; Mimata H; Yokoyama S
Pathol Int; 2017 Dec; 67(12):626-631. PubMed ID: 29024210
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
